“Comparison of the Efficacy of Generation 1 and 2 Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer Patients With EGFR Positive Mutations”. Indian Journal of Forensic Medicine & Toxicology, vol. 15, no. 3, May 2021, pp. 4316-24, https://doi.org/10.37506/ijfmt.v15i3.15970.